Table 4. Association between the expression of lncRNAs and the clinicopathological features in 84 patients with colorectal cancer.
| lncRNA | Differentiation types | P value | |
|---|---|---|---|
| Well (N = 22) | Moderate or others (N = 62) | ||
| AK098081 | 1.50±0.41 | 3.58±0.55 | 0.032 |
| BC040303 | 1.29±0.18 | 0.75±0.14 | 0.040 |
| CR749831 | 1.13±0.25 | 0.61±0.10 | 0.022 |
| BC037331 | 1.30±0.57 | 0.51±0.10 | 0.037 |
| lncRNA | N stagea | P-value | |
| N0 (n = 46) | N1,N2(n = 38) | ||
| BC037331 | 1.31±0.46 | 0.34±0.07 | 0.016 |
| lncRNA | CEAb (μg/ml) | P-value | |
| <5(n = 52) | ≥5(n = 32) | ||
| BC037331 | 1.10±0.31 | 0.41±0.43 | 0.035 |
The relative expression of lncRNA is expressed as 2-△△Ct (mean ± SE).
a: According to NCCN Guidelines Version 2.2012 Gastric Cancer Staging
b: carcinoembryonic antigen